Qiagen N.V.

QIA · Healthcare

About Qiagen N.V. (QIA)

Qiagen N.V. is a Diagnostics & Research company operating in the Healthcare sector. The company is headquartered in Venlo, Netherlands. QIA has been publicly traded since 1998, giving it 28+ years of trading history.

Qiagen N.V. (QIA) has been publicly traded since 1998, making it a 28-year-old public company. It operates in the Diagnostics & Research industry within the Healthcare sector. The company is headquartered in Venlo, Netherlands and employs approximately 5,700 people. With a market capitalization of €7.5 billion, QIA is a mid-sized company with growth potential.

QIA trades on the German stock exchanges (XETRA/Frankfurt) and is classified as a mid-cap-cap stock with a market capitalization of approximately €7.5 billion. The company employs approximately 5,700 people worldwide.

Sector
Healthcare
Industry
Diagnostics & Research
Headquarters
Venlo, Netherlands
IPO Year
1998

Key Statistics

Current Price
€36.04
Market Cap
€7.46B
52-Week High
€47.60
52-Week Low
€34.99
Sector
Healthcare
Industry
Diagnostics & Research

QIA Investment Performance

QIA has declined 6.6% year-to-date in 2026. Over the past 5 years, a €1,000 investment in QIA would have grown to €886, representing a -11.4% total return. Since its IPO in 1998, a €1,000 investment would now be worth €2,530.

€1,000 Invested in Qiagen N.V. (QIA)

1 Year
€996
+-0%
3 Years
€873
+-13%
5 Years
€886
+-11%
10 Years
€1,875
+87%
Since IPO
€2,530
+153%

How much would €1,000 invested in QIA be worth today?

What would €1,000 invested in QIA 1 year ago be worth today?

A €1,000 investment in Qiagen N.V. (QIA) in 2025 would be worth €996 as of March 2026, representing a -0.4% total return.

What would €1,000 invested in QIA 3 years ago be worth today?

A €1,000 investment in Qiagen N.V. (QIA) in 2023 would be worth €873 as of March 2026, representing a -12.7% total return.

What would €1,000 invested in QIA 5 years ago be worth today?

A €1,000 investment in Qiagen N.V. (QIA) in 2021 would be worth €886 as of March 2026, representing a -11.4% total return.

What would €1,000 invested in QIA 10 years ago be worth today?

A €1,000 investment in Qiagen N.V. (QIA) in 2016 would be worth €1,875 as of March 2026, representing a +87.5% total return.

What would €1,000 invested in QIA at IPO be worth today?

A €1,000 investment in Qiagen N.V. (QIA) at IPO would be worth €2,530 as of March 2026, representing a +153.0% total return.

Monthly Returns Heatmap

Avg Monthly Return
+0.97%
Positive Months
166
50% of 332
Negative Months
159
48% of 332
Data Period
27+ years
332 months
Best Performers
Best month ever: Aug 2003 (+110.0%)
Best month on avg: November (+4.7%)
Worst Performers
Worst month ever: Jul 1999 (-46.0%)
Worst month on avg: September (-2.7%)

Over the past 27+ years (332 months), Qiagen N.V. (QIA) has averaged a monthly return of +0.97% with a median return of +0.08%. The stock had 166 positive months (50%) and 159 negative months (48%). The best month in QIA's history was August 2003 with a +110.0% return, while the worst was July 1999 at -46.0%. Historically, November tends to be the strongest month (averaging +4.7%), and September the weakest (-2.7%).

QIA's longest winning streak was 7 consecutive months of gains, while its longest losing streak was 7 consecutive months of losses. The best full year was 2003 with a cumulative return of +109.4%, and the worst was 2002 at -107.2%.

Annual Returns

Over 28 years of trading history, Qiagen N.V. (QIA) has delivered an average annual return of +10.53% with a median return of +11.32%. The compound annual growth rate (CAGR) is +3.66%. The stock posted gains in 17 years (61%) and losses in 11 years (39%).

QIA's best year was 2000 with a +103.97% gain, while the worst was 2002 at -76.90%. The longest streak of consecutive positive years was 5, and the longest losing streak was 2 years. QIA achieved double-digit gains (10%+) in 14 years. It suffered double-digit losses in 6 years.

Avg Return
+10.53%
Best Year
2000 (+103.97%)
Worst Year
2002 (-76.90%)
Positive Years
17/28
Year Return Start End
2026 -6.58% €38.57 €36.03
2025 -9.09% €42.43 €38.57
2024 +9.32% €38.81 €42.43
2023 -16.19% €46.31 €38.81
2022 -4.04% €48.26 €46.31
2021 +15.41% €41.82 €48.26
2020 +39.36% €30.01 €41.82
2019 +2.63% €29.24 €30.01
2018 +13.33% €25.80 €29.24
2017 -1.49% €26.19 €25.80
2016 +6.23% €24.65 €26.19
2015 +29.73% €19.00 €24.65
2014 +14.32% €16.62 €19.00
2013 +23.16% €13.50 €16.62
2012 +29.11% €10.45 €13.50
2011 -27.20% €14.36 €10.45
2010 -6.34% €15.33 €14.36
2009 +26.27% €12.14 €15.33
2008 -16.53% €14.55 €12.14
2007 +27.54% €11.41 €14.55
2006 +16.90% €9.76 €11.41
2005 +23.48% €7.90 €9.76
2004 -17.27% €9.55 €7.90
2003 +100.62% €4.76 €9.55
2002 -76.90% €20.61 €4.76
2001 -45.45% €37.79 €20.61
2000 +103.97% €18.53 €37.79
1999 +40.56% €13.18 €18.53

QIA Investment Analysis: Valuation, Risk & Dividends

Key factors to consider when evaluating Qiagen N.V. as an investment

Valuation

QIA currently trades at a trailing P/E ratio of 20.4, which is considered moderate relative to the broader market. The forward P/E of 15.4 suggests analysts expect earnings to be lower in the coming year. The price-to-book ratio stands at 2.3. The price-to-sales ratio is 3.6.

Dividends

Qiagen N.V. pays a dividend to shareholders with a current yield of 0.62%. This translates to €0.22 per share annually. The payout ratio of 13% indicates sustainable dividend coverage.

Risk & Volatility

QIA has a beta of 0.71, indicating it is less volatile than the overall market. The stock's 52-week range is €34.99 to €47.59, and it currently trades near its 52-week low.

Analyst Ratings

Based on 7 analyst opinions, QIA has a consensus "none" rating. The average price target of €47.18 suggests 30.9% upside from current levels.

Frequently Asked Questions: QIA

What sector is QIA in?

QIA operates in the Healthcare sector, specifically in the Diagnostics & Research industry. This sector includes pharmaceutical companies, biotechnology firms, medical device manufacturers, and healthcare providers.

How has QIA performed historically?

Over 28 years of trading history, QIA has posted gains in 17 years (61% of the time). The best year was 2000 with a +104.0% return. Past performance does not guarantee future results.

How can I invest in QIA?

You can invest in QIA through any brokerage account that offers access to German exchanges. Popular options include commission-free brokers like Fidelity, Charles Schwab, or Robinhood (US), or international brokers like Interactive Brokers. You can buy individual shares or invest through ETFs that hold QIA.

Does QIA pay dividends?

Qiagen N.V. pays a dividend to shareholders with a current yield of 0.62%. This translates to €0.22 per share annually. The payout ratio of 13% indicates sustainable dividend coverage.

What does Qiagen N.V. do?

Qiagen N.V. is a Diagnostics & Research company operating in the Healthcare sector. The company is headquartered in Venlo, Netherlands.

What sector is QIA in?

QIA operates in the Healthcare sector, specifically in the Diagnostics & Research industry.

When did QIA go public?

Qiagen N.V. went public in 1998, making it a 28-year-old public company as of 2026.

How much would €1,000 invested in QIA 5 years ago be worth today?

A €1,000 investment in QIA five years ago would be worth approximately €886 today, representing a -11.4% return.

How much would €1,000 invested in QIA 10 years ago be worth today?

A €1,000 investment in QIA ten years ago would be worth approximately €1,875 today, representing a 87.5% total return over the decade.

What is QIA's 3-year return?

Over the past 3 years, QIA has returned -12.7%. A €1,000 investment would have grown to €873.

How much would €1,000 invested in QIA at IPO be worth today?

If you invested €1,000 in QIA at its IPO in 1998, it would be worth approximately €2,530 today, a 153.0% return over 28 years.

Does QIA pay dividends?

Yes, Qiagen N.V. pays a dividend with a current yield of 0.62%, which is €0.22 per share annually.

What is QIA's market cap?

Qiagen N.V. has a market capitalization of €7.5 billion, classifying it as a mid-cap company.

What is QIA's P/E ratio?

QIA has a trailing P/E ratio of 20.4 and a forward P/E of 15.4, which measures how much investors are paying per dollar of earnings.

Is QIA a buy, hold, or sell?

Based on 7 opinions, QIA has a consensus "none" rating. The average price target is €47.18.

Last updated: 3/15/2026